Heart failure: How can we prevent the epidemic?

Medical Journal of Australia

Volumn 179, Issue 8, 2003, Pages 422-425

  Campbell, Duncan J ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMMUNITY CARE; DIABETES MELLITUS; DIET; DRUG EFFICACY; ENVIRONMENTAL FACTOR; EPIDEMIC; FAMILY; GENERAL PRACTICE; HEALTH EDUCATION; HEALTH PROGRAM; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LAW; LIFESTYLE; LONG TERM CARE; OBESITY; PREVALENCE; PREVENTIVE MEDICINE; PRIMARY HEALTH CARE; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SURVIVAL;

EID: 0142260960     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05620.x     Document Type: Review

References (35)

1. Blyth FM, Lazarus R, Ross D, et al. Burden and outcomes of hospitalisation for congestive cardiac failure. Med J Aust 1997; 167: 67-70.
2. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure. The Framingham Heart Study. Circulation 2002; 106: 3068-3072.
3. Australian Institute of Health and Welfare. Field B. Heart Failure ⋯ What of the Future? AIHW Bulletin No. 6. Canberra: AIHW, 2003. (AIHW Catalogue No. AUS-34.)
4. Morgan S, Smith H, Simpson I, et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: Cross sectional survey. BMJ 1999; 318: 368-372.
5. Krum H, Tonkin AM, Currie R, et al. Chronic heart failure in Australian general practice. The Cardiac Awareness Survey and Evaluation (CASE) Study. Med J Aust 2001; 174: 439-444.
6. Macdonald PS, O'Rourke MF. Cardiovascular ageing and heart failure. Med J Aust 1998; 169: 480-484.
7. Yusuf S, Pitt B. A lifetime of prevention: The case of heart failure. Circulation 2002; 106: 2997-2998.
8. Horowitz JD, Stewart S. Heart failure in older people: The epidemic we had to have. Med J Aust 2001; 174: 432-433.
9. Rose G. The Strategy of Preventive Medicine. Oxford: Oxford University Press, 1992.
10. Beaglehole R, Magnus P. The search for new risk factors for coronary heart disease: Occupational therapy for epidemiologists? Int J Epidemiol 2002; 31: 1117-1122; author reply 1134-1135.
11. Australian Institute of Health and Welfare. Heart, Stroke and Vascular Diseases - Australian Facts 2001. Canberra: AIHW, National Heart Foundation of Australia, National Stroke Foundation of Australia, 2001. (Cardiovascular Disease Series No. 14).
12. Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: The 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003; 178: 427-432.
13. Massie BM. Obesity and heart failure - Risk factor or mechanism? N Engl J Med 2002; 347: 358-359.
14. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part I: Aging arteries: A "set up" for vascular disease. Circulation 2003; 107: 139-146.
15. Tonkin AM, Lim SS, Schirmer H. Cardiovascular risk factors: When should we treat? Med J Aust 2003; 178: 101-102.
16. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Guidelines on the contemporary management of the patient with chronic heart failure in Australia. 2002. Available at: www.heartfoundation.com.au/downloads/cont.management.pdf (accessed Aug 2003).
17. Estimating coronary heart disease (CHD) risk using Framingham Heart Study prediction score sheets. Available at: rover2.nhlbi.nih.gov/about/framingham/riskabs.htm (accessed Aug 2003).
18. New Zealand Guidelines Group. Estimation of cardiovascular risk for men and women. Available at: www.nzgg.org.nz/library/gl_complete/bloodpressure/table1.cfm (accessed Jul 2003).
19. Vale MJ, Jelinek MV, Best JD, et al. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000. Med J Aust 2002; 176: 211-215.
20. Wing LMH, Reid CM, Ryan P, et al. Second Australian National Blood Pressure Study (ANBP2) - Comparative outcome trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly: Principal results. N Engl J Med 2003; 348: 583-592.
21. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124.
22. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.
23. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
24. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
25. Sdringola S, Nakagawa K, Nakagawa Y, et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol 2003; 41: 263-272.
26. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998; 338: 1650-1656.
27. Magarey AM, Daniels LA, Boulton TJ, et al. Predicting obesity in early adulthood from childhood and parental obesity. Int J Obes Relat Metab Disord 2003; 27: 505-513.
28. Egger G, Swinburn B. An "ecological" approach to the obesity pandemic. BMJ 1997; 315: 477-480.
29. Pearson TA, Bazzarre TL, Daniels SR, et al. American Heart Association guide for improving cardiovascular health at the community level. A statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 2003; 107: 645-651.
30. Dabkowski S. McDonald's begins to see the light. The Age (Melbourne) 2003 Jun 30: 3.
31. Harris MF, Mercer PJ. Reactive or preventive: The role of general practice in achieving a healthier Australia. Med J Aust 2001; 175: 92-93.
32. Steptoe A, Perkins-Porras L, McKay C, et al. Behavioural counselling to increase consumption of fruit and vegetables in low income adults: Randomised trial. BMJ 2003; 326: 855-860.
33. Vale MJ, Jelinek MV, Best JD, et al. Coaching patients with coronary heart disease to achieve the target cholesterol: A method to bridge the gap between evidence-based medicine and the "real world" - Randomized controlled trial. J Clin Epidemiol 2002; 55: 245-252.
34. McKinlay JB. More appropriate evaluation methods for community-level health interventions. Introduction to the special issue. Eval Rev 1996; 20: 237-243.
35. Australian Research Alliance for Children and Youth. Available at: www.aracy.org.au (accessed Jul 2003).